ECM Weekly (1 September 2018) - Meituan, NIO, Aavas, Hua Medicine, Qutoutiao
Aequitas Research puts out a weekly update on the deals that have been covered by Smartkarma Insight Providers recently, along with updates for...
426 Views
Hua Medicine (华领医药) IPO: Little Upside to Fair Value
Hua Medicine launched the institutional book building today and intends to raise USD 111 to USD 124 million, with an implied market capitalization...
517 Views
Hua Medicine (华领医药) IPO: Thoughts on Valuation
Hua Medicine recently received approval for its listing application to raise USD 200 million. In our previous insight (Hua Medicine (华领医药) IPO:...
534 Views
Hua Medicine (华领医药) IPO: Reviving Roche's Failed Attempt?
Hua Medicine, a China-based drug development with type 2 diabetes drug in its pipeline, plans to list on the Hong Kong Stock Exchange. The company...
1.1k Views
ECM Coverage Weekly Update (18 August 2018)
Aequitas Research puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. This week, the market was...
480 Views